According to a United States Centers for Disease Control and Prevention (CDC) media statement released to the public yesterday, the CDC was informed by Merck on Monday that the pharmaceutical company planned to implement a recall of one lot (lot J007354) of Gardasil® [Human Papillomavirus Quadrivalent (types 6, 11, 16, and 18) Vaccine, Recombinant], due to the potential for a number of vials to contain glass particles as a result of breakage during the manufacturing process.
Merck estimates that approximately ten of the 743,360 vials in the affected lot could have glass particles in them. The HPV vaccines from the affected lot were distributed between August 20, 2013, and October 9, 2013.
If a vaccine containing glass particles (tiny enough to get through a needle) is given to a patient, reactions like redness or swelling at the injection site routinely seen after vaccination may occur. The Merck recall does not affect the supply of vaccine. Clinicians should report adverse events following vaccination to the Vaccine Adverse Event Reporting System (VAERS).
The Japanese government has withdrawn administration of vaccines against Human Papillomavirus ( HPV) in Kitui citing adverse effects including infertility, long-term pain, numbness and paralysis as the World Health Organisation ( WHO) faces criticism for their position that endorses the HPV vaccines’ efficacy and claim that they are useful tools for preventing cervical cancer. See: http://www.examiner.com/article/world-health-organization-accused-of-promoting-vaccines-to-benefit-manufacturers
Don't miss another article! Subscribe to email alerts here: http://www.examiner.com/healthy-living-in-miami/jeannie-stokowski-bisanti